A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Viatris Inc stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 3,023,525 shares of VTRS stock, worth $35.1 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,023,525
Previous 3,537,903 14.54%
Holding current value
$35.1 Million
Previous $42.2 Million 23.91%
% of portfolio
0.11%
Previous 0.16%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.05 - $12.02 $5.17 Million - $6.18 Million
-514,378 Reduced 14.54%
3,023,525 $32.1 Million
Q1 2024

May 14, 2024

SELL
$11.27 - $13.53 $6.93 Million - $8.32 Million
-614,836 Reduced 14.81%
3,537,903 $42.2 Million
Q4 2023

Feb 13, 2024

BUY
$8.77 - $10.85 $5.1 Million - $6.31 Million
581,574 Added 16.29%
4,152,739 $45 Million
Q3 2023

Nov 13, 2023

BUY
$9.59 - $11.35 $1.88 Million - $2.22 Million
195,651 Added 5.8%
3,571,165 $35.2 Million
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $4.45 Million - $5.08 Million
-493,280 Reduced 12.75%
3,375,514 $33.7 Million
Q1 2023

May 12, 2023

BUY
$9.2 - $12.26 $1.74 Million - $2.32 Million
189,500 Added 5.15%
3,868,794 $37.2 Million
Q4 2022

Feb 13, 2023

BUY
$8.72 - $11.56 $5.64 Million - $7.48 Million
647,094 Added 21.34%
3,679,294 $41 Million
Q3 2022

Nov 10, 2022

BUY
$8.48 - $11.13 $3.38 Million - $4.43 Million
398,400 Added 15.13%
3,032,200 $25.8 Million
Q2 2022

Aug 12, 2022

BUY
$9.95 - $12.27 $1.08 Million - $1.34 Million
109,000 Added 4.32%
2,633,800 $27.6 Million
Q1 2022

May 13, 2022

BUY
$9.81 - $15.4 $7.4 Million - $11.6 Million
754,100 Added 42.59%
2,524,800 $27.5 Million
Q4 2021

Feb 11, 2022

SELL
$12.09 - $14.68 $1.6 Million - $1.94 Million
-132,400 Reduced 6.96%
1,770,700 $24 Million
Q3 2021

Nov 12, 2021

BUY
$13.25 - $15.13 $3.87 Million - $4.42 Million
292,400 Added 18.15%
1,903,100 $25.8 Million
Q2 2021

Aug 12, 2021

BUY
$12.97 - $16.15 $4.01 Million - $4.99 Million
308,911 Added 23.73%
1,610,700 $23 Million
Q1 2021

May 13, 2021

BUY
$13.59 - $18.54 $8.75 Million - $11.9 Million
644,032 Added 97.91%
1,301,789 $18.2 Million
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $9.41 Million - $12.3 Million
657,757 New
657,757 $12.3 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track Jeremy Grantham's Portfolio

Track Jeremy Grantham Portfolio

Follow Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.